Clinical Programs
The Section of Hematology/Oncology at The University of Chicago is dedicated to providing comprehensive, multidisciplinary care and advanced research in the treatment of adult hematologic and oncologic diseases. Each year, our experts care for approximately 5,000 new patients who seek our help for various blood disorders and cancers.
Our dedicated faculty manage four inpatient services and a general consultation service, working alongside an exceptional team of nurses, advanced practice providers (APPs), medical assistants (MAs), technicians, mental health professionals, and colleagues from other Sections and Departments. The Section consistently receives national recognition as one of the top cancer programs in the country, with many of our physicians earning accolades for their outstanding patient care year after year. This includes having more physicians consistently recognized as top doctors in the Chicagoland area than any other institution.
The hallmark of our Section is the compassionate, high-quality clinical care our physicians deliver to patients. Many of our programs seamlessly incorporate clinical trials into their treatment offerings, ensuring that our patients have access to cutting-edge therapies. Led by our expert faculty, clinical trials research efforts are supported by a dedicated team of research nurses, data analysts, research coordinators, technicians, and regulatory specialists. Currently, we offer over 200 investigator-initiated and industry-sponsored clinical trials for patients with:
- Leukemia, lymphoma, myeloma, and other hematologic malignancies
- Lung cancer
- Head and neck cancer
- Breast cancer
- Gastrointestinal cancer
- Genitourinary cancer
- Mesothelioma
- Melanoma/sarcoma
- Other solid tumors
For more information about the clinical services we offer, please visit The University of Chicago Medicine website.